DURACTON Trademark
Trademark Overview
On Monday, March 14, 1960, a trademark application was filed for DURACTON with the United States Patent and Trademark Office. The USPTO has given the DURACTON trademark a serial number of 72092794. The federal status of this trademark filing is EXPIRED as of Thursday, February 11, 1988. This trademark is owned by NORDIC BIOCHEMICALS LIMITED. The DURACTON trademark is filed in the Pharmaceutical Products category with the following description:
PHARMACEUTICAL PREPARATION, SPECIFICALLY A DRUG SOLD AS A HIGHLY PURIFIED ADRENOCORTICOTROPHIC HORMONE PREPARATION COMPOUNDED WITH CARBOXYMETHYLCELLULOSE
General Information
Serial Number | 72092794 |
Word Mark | DURACTON |
Filing Date | Monday, March 14, 1960 |
Status | 900 - EXPIRED |
Status Date | Thursday, February 11, 1988 |
Registration Number | 0746476 |
Registration Date | Tuesday, March 12, 1963 |
Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
Goods and Services | PHARMACEUTICAL PREPARATION, SPECIFICALLY A DRUG SOLD AS A HIGHLY PURIFIED ADRENOCORTICOTROPHIC HORMONE PREPARATION COMPOUNDED WITH CARBOXYMETHYLCELLULOSE |
Classification Information
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 018 |
Class Status Code | 9 - Expired |
Class Status Date | Thursday, February 11, 1988 |
Primary Code | 018 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | NORDIC BIOCHEMICALS LIMITED |
Party Type | 30 - Original Registrant |
Legal Entity Type | 03 - Corporation |
Address | MONTREAL, QUEBEC CA |
Trademark Events
Event Date | Event Description |
Thursday, February 11, 1988 | EXPIRED SEC. 9 |